TREA

79338455 - AUTOLUS

Follow

Information

  • Trademark
  • 79338455
  • Serial Number
    79338455
  • Registration Number
    7095476
  • Filing Date
    March 02, 2022
    2 years ago
  • Registration Date
    July 04, 2023
    a year ago
  • Transaction Date
    October 31, 2023
    a year ago
  • Status Date
    July 04, 2023
    a year ago
  • Published for Opposition Date
    April 18, 2023
    a year ago
  • Location Date
    July 04, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    WEIGLE, KATHERINE CONN
  • Attorney Docket Number
    60895-576925
    Attorney Name
    Rebecca Liebowitz
    Law Office Assigned Location Code
    L10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
AUTOLUS
Case File Statements
  • GS0051: Medical and veterinary preparations for therapeutic purposes, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical preparations for cell therapy, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical preparations for gene therapy, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical preparations for the treatment of cancer; cells for medial or clinical use, namely cells featuring chimeric antigen receptors (CAR) and therapeutic preparations thereof, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; antibodies for medical purposes for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors, namely, culture media for cultivating and augmentation of human and animal cells; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes
  • GS0441: Medical services; veterinary services; medical and veterinary services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes namely, medical services relating to the removal, treatment and processing of human and animal cells; medical and veterinary services in the nature of reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies
  • GS0421: Scientific and technological services and research and design relating thereto, namely medical research, scientific research, analysis and testing in the field of human and animal cell and gene therapies, pharmaceutical product development, research and development of new products; industrial analysis and research services in the field of cell and gene therapies ; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services
Case File Event Statements
  • 10/31/2023 - a year ago
    25 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 10/6/2023 - a year ago
    24 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 10/5/2023 - a year ago
    23 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 10/4/2023 - a year ago
    22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 7/4/2023 - a year ago
    21 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 7/4/2023 - a year ago
    20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/9/2023 - a year ago
    19 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 4/18/2023 - a year ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/18/2023 - a year ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/5/2023 - a year ago
    16 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 4/5/2023 - a year ago
    15 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 3/29/2023 - a year ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/15/2023 - a year ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/13/2023 - a year ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/11/2023 - a year ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/11/2023 - a year ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/5/2023 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/9/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/8/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/15/2022 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/14/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/14/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/19/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 4/15/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/14/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC